I agree that this site is using cookies. You can find further informations here.
X
Adamsick, Meagan L
30  results:
Search for persons X
?
1

Baseline procalcitonin as a predictor of bacterial infectio..:

Atallah, Natalie J. ; Warren, Hailey M. ; Roberts, Matthew B....
PLOS ONE.  17 (2022)  1 - p. e0262342 , 2022
Link: https://doi.org/10.1371/..
 
?
2

1155. Short vs. Long Symptom Duration Prior to Remdesivir f..:

Elshaboury, Ramy H ; Adamsick, Meagan L ; Huang, Joanne...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
3

Remdesivir use and outcomes during the FDA COVID-19 emergen..:

Elshaboury, Ramy H. ; Monk, Miranda M. ; Bebell, Lisa M....
Therapeutic Advances in Infectious Disease.  8 (2021)  - p. 204993612110466 , 2021
Link: https://doi.org/10.1177/..
 
?
4

Therapeutic drug monitoring of flucytosine in a cardiac tra..:

Williams, Kelsey N. ; Bidell, Monique R. ; Adamsick, Meagan L....
Transplant Infectious Disease.  23 (2021)  4 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
5

Clinical Outcomes and Economic Impact of Oritavancin for Gr..:

Brownell, Lauren E. ; Adamsick, Meagan L. ; McCreary, Erin K....
Drugs - Real World Outcomes.  7 (2020)  S1 - p. 13-19 , 2020
Link: https://doi.org/10.1007/..
 
?
6

1482. Local validation of the drug resistance in pneumonia ..:

Reinhard, Jennifer L ; Elshaboury, Ramy H ; Hayes, Bryan D...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S742-S743 , 2020
Link: https://doi.org/10.1093/..
 
?
7

61. Evaluation of the Impact of a Micafungin Time-Out Proto..:

Williams, Kelsey N ; Elshaboury, Ramy H ; Letourneau, Alyssa R...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S51-S51 , 2020
Link: https://doi.org/10.1093/..
 
?
8

756. Impact of Infectious Diseases Pharmacists as Part of a..:

Adamsick, Meagan L ; Gandhi, Ronak G ; Steiger, Samantha N...
Open Forum Infectious Diseases.  6 (2019)  Supplement_2 - p. S337-S338 , 2019
Link: https://doi.org/10.1093/..
 
?
9

Therapeutic drug concentrations of isavuconazole following ..:

Adamsick, Meagan L. ; Elshaboury, Ramy H. ; Gift, Thais...
Transplant Infectious Disease.  21 (2019)  2 - p. , 2019
Link: https://doi.org/10.1111/..
 
?
10

Remdesivir use and outcomes during the FDA COVID-19 emergen..:

Elshaboury, Ramy H ; Monk, Miranda M ; Bebell, Lisa M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474339/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Authors' Reply:

Adamsick, Meagan L ; Bhattacharyya, Roby P ; Sise, Meghan E
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054901/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

1482. Local validation of the drug resistance in pneumonia ..:

Reinhard, Jennifer L ; Elshaboury, Ramy H ; Hayes, Bryan D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778133/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
13

61. Evaluation of the Impact of a Micafungin Time-Out Proto..:

Williams, Kelsey N ; Elshaboury, Ramy H ; Letourneau, Alyssa R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777059/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
14

Clinical Outcomes and Economic Impact of Oritavancin for Gr..:

Brownell, Lauren E ; Adamsick, Meagan L ; McCreary, Erin K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334320/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
15

Risk of Serotonin Syndrome with Isoniazid:

O'Brien, Michael E ; Gandhi, Ronak G ; Kotton, Camille N.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927797/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
1-15